Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) (pTyr249) antibody

Details for Product No. ABIN967617, Supplier: Log in to see
Antigen
  • MGC68466
  • cas
  • Crkas
  • p130cas
  • BCAR1
  • fc17f11
  • wu:fc17f11
  • zgc:175192
  • CAS
  • CAS1
  • CASS1
  • CRKAS
  • P130Cas
  • AI385681
  • Cas
  • P130CAS
  • breast cancer anti-estrogen resistance 1
  • breast cancer anti-estrogen resistance 1-like
  • bcar1
  • BCAR1
  • Bcar1
  • LOC100350323
Alternatives
anti-Human Breast Cancer Anti-Estrogen Resistance 1 antibody for ELISA
Epitope
pTyr249
33
25
15
9
7
5
5
4
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivity
Human
172
110
109
14
11
5
3
2
2
2
1
1
1
1
1
Host
Mouse
131
35
11
3
Clonality (Clone)
Monoclonal ()
Conjugate
Un-conjugated
6
4
4
4
4
3
3
3
3
3
3
3
3
3
2
1
1
Application
Western Blotting (WB)
129
52
47
41
39
30
14
12
8
3
3
2
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Brand BD Pharmingen™
Immunogen Phosphorylated Human p130Cas
Clone J169-757-12-2
Isotype IgG2b, kappa
Characteristics 1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Please refer to us for technical protocols.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
Purification The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
Alternative Name p130 Cas (BCAR1 Antibody Abstract)
Background P47v-crk (v-Crk) is the product of a transforming gene, v-crk, that was isolated from avian sarcoma viruses. The v-Crk protein is a fusion product of viral Gag protein and a part of cellular Crk that includes SH2 and SH3 domains. v-Crk-induced transformation increases tyrosine phosphorylation of several cellular proteins, including p130Cas (CRK-associated substrate). The p130Cas is tightly associated with v-Crk via the SH2 domain of v-Crk. Tyrosine phosphorylation of p130Cas occurs in conjunction with cellular transformation in cells that express v-Src or v-Crk. This phosphorylation leads to a change in p130Cas localization from the cytoplasm to the cell membrane and, possibly, to the nucleus. Since p130Cas also associates with v-Src, it may be a v-Src substrate. Several phosphorylation sites have been described in p130Cas upon Fibroblast Growth Factor stimulation, and phosphorylated tyrosine (Y249) might function as a binding site for the Crk-adaptor molecule.
The J169-757.12.2 monoclonal antibody recognizes the phosphorylated Y249 of human p130Cas. The orthologous phosphorylation sites in mouse and rat p130Cas are Y253 and Y347, respectively.
Molecular Weight 130 kDa
Pathways EGFR Signaling Pathway, Neurotrophin Signaling Pathway, CXCR4-mediated Signaling Events, Platelet-derived growth Factor Receptor Signaling
Comment

Related Products: ABIN967389

Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Buffer Aqueous buffered solution containing ≤0.09 % sodium azide.
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Storage Comment Store undiluted at 4°C.
Supplier Images
Western Blotting (WB) image for anti-Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) (pTyr249) antibody (ABIN967617) Western blot analysis of p130Cas (pY249) in human Burkitt’s lymphoma. Lysates from co...
Product cited in: Goldberg, Alexander, Pellicena, Zhang, Tsuda, Miller: "Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells." in: The Journal of biological chemistry, Vol. 278, Issue 47, pp. 46533-40, 2003 (PubMed).

Hinsby, Olsen, Bennett, Mann: "Signaling initiated by overexpression of the fibroblast growth factor receptor-1 investigated by mass spectrometry." in: Molecular & cellular proteomics : MCP, Vol. 2, Issue 1, pp. 29-36, 2003 (PubMed).